Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study tool

Benzodiazepines (BZDs) are anxiolytic drugs that act on GABAa receptors and are used to treat anxiety disorders. However, these drugs come with the detrimental side effect of anterograde amnesia, or the inability to form new memories. In this review we discuss, behavioral paradigms, sex differences...

Celý popis

Podrobná bibliografie
Hlavní autoři: Kameron Kaplan, Holly Christian Hunsberger
Médium: Článek
Jazyk:English
Vydáno: Frontiers Media S.A. 2023-09-01
Edice:Frontiers in Pharmacology
Témata:
On-line přístup:https://www.frontiersin.org/articles/10.3389/fphar.2023.1257030/full
_version_ 1827818765432127488
author Kameron Kaplan
Kameron Kaplan
Holly Christian Hunsberger
Holly Christian Hunsberger
author_facet Kameron Kaplan
Kameron Kaplan
Holly Christian Hunsberger
Holly Christian Hunsberger
author_sort Kameron Kaplan
collection DOAJ
description Benzodiazepines (BZDs) are anxiolytic drugs that act on GABAa receptors and are used to treat anxiety disorders. However, these drugs come with the detrimental side effect of anterograde amnesia, or the inability to form new memories. In this review we discuss, behavioral paradigms, sex differences and hormonal influences affecting BZD-induced amnesia, molecular manipulations, including the knockout of GABAa receptor subunits, and regional studies utilizing lesion and microinjection techniques targeted to the hippocampus and amygdala. Additionally, the relationship between BZD use and cognitive decline related to Alzheimer’s disease is addressed, as there is a lack of consensus on whether these drugs are involved in inducing or accelerating pathological cognitive deficits. This review aims to inspire new research directions, as there is a gap in knowledge in understanding the cellular and molecular mechanisms behind BZD-induced amnesia. Understanding these mechanisms will allow for the development of alternative treatments and potentially allow BZDs to be used as a novel tool to study Alzheimer’s disease.
first_indexed 2024-03-12T00:58:05Z
format Article
id doaj.art-5a8a6ac3c73b4f1e94a74ae4a95294f4
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-12T00:58:05Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-5a8a6ac3c73b4f1e94a74ae4a95294f42023-09-14T10:21:51ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-09-011410.3389/fphar.2023.12570301257030Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study toolKameron Kaplan0Kameron Kaplan1Holly Christian Hunsberger2Holly Christian Hunsberger3Center for Neurodegenerative Diseases and Therapeutics, Rosalind Franklin University of Medicine and Science, North Chicago, IL, United StatesDepartment of Neuroscience, Rosalind Franklin University of Medicine and Science, The Chicago Medical School, North Chicago, IL, United StatesCenter for Neurodegenerative Diseases and Therapeutics, Rosalind Franklin University of Medicine and Science, North Chicago, IL, United StatesDepartment of Neuroscience, Rosalind Franklin University of Medicine and Science, The Chicago Medical School, North Chicago, IL, United StatesBenzodiazepines (BZDs) are anxiolytic drugs that act on GABAa receptors and are used to treat anxiety disorders. However, these drugs come with the detrimental side effect of anterograde amnesia, or the inability to form new memories. In this review we discuss, behavioral paradigms, sex differences and hormonal influences affecting BZD-induced amnesia, molecular manipulations, including the knockout of GABAa receptor subunits, and regional studies utilizing lesion and microinjection techniques targeted to the hippocampus and amygdala. Additionally, the relationship between BZD use and cognitive decline related to Alzheimer’s disease is addressed, as there is a lack of consensus on whether these drugs are involved in inducing or accelerating pathological cognitive deficits. This review aims to inspire new research directions, as there is a gap in knowledge in understanding the cellular and molecular mechanisms behind BZD-induced amnesia. Understanding these mechanisms will allow for the development of alternative treatments and potentially allow BZDs to be used as a novel tool to study Alzheimer’s disease.https://www.frontiersin.org/articles/10.3389/fphar.2023.1257030/fullbenzodiazepinesanterograde amnesiasex differencesAlzheimer’s diseaseGABAAfear conditioning
spellingShingle Kameron Kaplan
Kameron Kaplan
Holly Christian Hunsberger
Holly Christian Hunsberger
Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study tool
Frontiers in Pharmacology
benzodiazepines
anterograde amnesia
sex differences
Alzheimer’s disease
GABAA
fear conditioning
title Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study tool
title_full Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study tool
title_fullStr Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study tool
title_full_unstemmed Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study tool
title_short Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study tool
title_sort benzodiazepine induced anterograde amnesia detrimental side effect to novel study tool
topic benzodiazepines
anterograde amnesia
sex differences
Alzheimer’s disease
GABAA
fear conditioning
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1257030/full
work_keys_str_mv AT kameronkaplan benzodiazepineinducedanterogradeamnesiadetrimentalsideeffecttonovelstudytool
AT kameronkaplan benzodiazepineinducedanterogradeamnesiadetrimentalsideeffecttonovelstudytool
AT hollychristianhunsberger benzodiazepineinducedanterogradeamnesiadetrimentalsideeffecttonovelstudytool
AT hollychristianhunsberger benzodiazepineinducedanterogradeamnesiadetrimentalsideeffecttonovelstudytool